Click to subscribe to the SADAG newsletter.
If you are interested in starting a Support Group, please contact Naazia on (011) 262 6396.
To find a Support Group in your area, please phone SADAG on (011) 262 6396.
Literacy is a luxury that many of us take for granted. We depend on written communication for information, guidance, and access to heath care information That is why SADAG created SPEAKING BOOKS and revolutionized the way information is delivered to low literacy communities. It's exactly what it sounds like.a book that talks to the reader in his or her local language, delivering critical information in an interactive, and educational way.
The customizable 16-page book, accompanied by local celebrity audio recordings, ensures that vital health and social messages can be seen, heard, read and understood..
We started with books on Teen Suicide prevention , HIV, AIDS and Depression, Understanding Mental Health and have developed over 30 titles, such as TB, Malaria, Polio, Vaccines for over 30 countries.
- Click here to see speaking books in action
- Click here for sample book on clinical trials
- Click here for latest press release 1.
- Click here for latest press release 2.
- Click here to connect to international site www.booksofhope.com
- Speaking books in South African community YouTube
- Speaking books for Health Care YouTube
Some teens with treatment-resistant depression are more likely than others to get well during a second treatment attempt of combination therapy, but various factors can hamper their recovery, according to an NIMH-funded study published online ahead of print February 4, 2009, in the Journal of the American Academy of Child and Adolescent Psychiatry.
About 40 percent of teens with major depression do not get well after a first treatment attempt with an antidepressant medication. The NIMH-funded Treatment of Resistant Depression in Adolescents (TORDIA) study was designed to test second-step treatment strategies for these teens.
In TORDIA, 334 teens who did not get well after taking a type of antidepressant called a selective serotonin reuptake inhibitor (SSRI) before the trial were randomly assigned to one of four treatments for 12 weeks:
· Switch to another SSRI
· Switch to venlafaxine, a different type of antidepressant
· Switch to another SSRI and add cognitive behavioral therapy (CBT), a type of psychotherapy
· Switch to venlafaxine and add CBT
Results of the trial, which were reported in February 2008, showed that the teens who received medication plus CBT were more likely to get well than those who switched medications only. In this most recent data analysis, Joan Rosenbaum Asarnow, Ph.D., of the University of California Los Angeles, and colleagues aimed to identify how to better predict a teen's response to treatment, and any factors that might affect response.
Results of the Study
Many predictors were similar to those found in studies of first-step treatments, such as the NIMH-funded Treatment for Adolescents with Depression Study (TADS), underscoring the importance of early treatment before the depression becomes chronic. For instance, like in TADS, teens in the TORDIA study were less likely to respond to treatment if they had very severe depression or higher levels of suicidal thinking. In addition, teens prone to self-harming behavior and family conflict were less likely to respond to treatment.
In contrast to TADS, however, the TORDIA teens with coexisting disorders, such as an anxiety disorder, attention deficit hyperactivity disorder (ADHD), or others, did respond to TORDIA's combination therapy. The researchers theorize that in this SSRI-resistant group, adding a CBT framework may have helped the teens deal with difficulties associated with coexisting disorders. In addition, the type of CBT used in the trial included general strategies for coping with a wide range of disorders, such as ways of solving problems and improving social functioning. Because community settings often must treat patients with coexisting disorders, this finding supports the use of CBT with patients who have complex diagnoses, according to the researchers.
Combination treatment, however, was not as beneficial for teens with a history of abuse, and those reporting high levels of hopelessness. This suggests a need to strengthen treatment strategies for teens suffering from these problems, said the researchers.
Knowing predictors and moderators of treatment response may help identify the most appropriate treatment for each individual.
"Selecting the optimal treatment for teens with depression is particularly crucial for those who do not respond to an initial treatment, because when depression is unremitting, teens and their parents often give up, which makes them less likely to stick to treatment," concluded Dr. Asarnow. "With this new data, personalizing depression treatment based on a teen's individual circumstances becomes a real possibility."
AstraZeneca Bipolar Line
0800 70 80 90
Dr Reddy's Help Line
0800 21 22 23
Pharmadynamics Police &Trauma Line
0800 20 50 26
Sanofi Aventis Sleep Line
(0800 753 379)
Suicide Crisis Line
0800 567 567
Akeso psychiatric reponse unit Gauteng Emergencies 24 hour
010 040 HELP (4357)
Department of Social Development Substance Abuse Line 24hr helpline
0800 12 13 14
SADAG Mental Health Line
011 262 6396
CALENDAR OF EVENTS 2014
Teen Suicide Prevention Week
16 - 22 February
Bipolar Awareness Day
Substance Abuse Awareness Day
Mental Health Awareness Month
1 – 31 July
Panic Awareness Day
World Suicide Prevention Day
World Mental Health Day
Want to become a volunteer counsellor? Contact Kalina (011) 262 6396
Download Application Form Here
If you are a journalist writing a story contact Cassey on
011 262 6396 / email@example.com